ARCHIVES

HHS Debars Straus, Who Concedes “Serious Deficiencies” In Trials

This article is from The Cancer Letter archive.

Vol. 08 No. 21 | May 21, 1982

Download PDF Visit The Full Archive

Related Articles

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

August 31, 2012

In Brief: Phillip Sharp Selected Next MIT President; Montgomery Retires From SRI Administration

February 23, 1990

Estrogen Alone Didn’t Increase Lung Cancer Mortality In WHI

August 27, 2010

Texas Cancer Plan Features Big Hike in Cigarette Tax

September 19, 1986

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009